Tejnaksh Healthcare Ltd.BSE: TEJNAKSH

Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Disclosure Pursuant To Regulation 30.

· Issued by Tejnaksh Healthcare Ltd. via BSE India

1.Considered and approved Audited Financial Results (Standalone & Consolidated) for the quarter and Year ended on March 31, 2026, and Auditors Report thereon;2. A declaration pursuant to Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2015, regarding unmodified opinion of the Statutory Auditors on the annual financial results for the financial year ended March 31, 2026.3.Consider and approved the re-appointment of M/s Kapil Tulsani & Associates as the Internal Auditor of the Company for a period commencing from April 1, 2026, and ending on March 31, 2027.4. The Board discussed the matter relating to the proposed offer of shares via Rights Issue and decided not to proceed further with the Rights Issue, in view of the postponement of the Company's expansion plans.5. The Board has authorized Directors Dr Ashish Rawandale Managing Director of the Company to sign and submit requisite forms with the Registrar of Companies (ROC) for the financial years 2026-2027.

View Attachment

View original source (BSE India)Tejnaksh Healthcare Ltd. on 6ix

Earlier from Tejnaksh Healthcare

Later from Tejnaksh Healthcare

All Tejnaksh Healthcare news releases